InsiderTrades

Form 4 for SPRB SPRUCE BIOSCIENCES, INC.

Accepted 2023-12-18 00:00:00 ET · period of report 2023-12-14 · accession 0001209191-23-059055 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-12-18 2023-12-15 SPRB Charlton Ralph William III Chief Medical Off F - Tax $1.66 -11.0K 46.0K -19% -$18.2K
D 2023-12-18 2023-12-15 SPRB Charlton Ralph William III Chief Medical Off M - OptEx $0.00 +31.8K 57.0K +126% $0
D 2023-12-18 2023-12-14 SPRB Charlton Ralph William III Chief Medical Off A - Grant $0.00 +212.8K 212.8K New $0
D 2023-12-18 2023-12-15 SPRB Charlton Ralph William III Chief Medical Off M - OptEx $0.00 -31.8K 95.2K -25% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-12-15 F D 10,980 $1.66 46,012 D — — (F1) On December 5, 2022, the Reporting Person was granted 127,000 time-based restricted stock units ("RSUs"), subject to a 4-year vesting schedule, with 25% of the total number of RSUs to vest on December 15, 2023 (the "Annual Vesting Date") and 25% of the total number of RSUs to vest in annual installments on each anniversary of the Annual Vesting Date thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). On December 15, 2023, 31,750 RSUs vested, with 10,980 shares being withheld for taxes, resulting in a net issuance of 20,770 shares.
2 Common Common Stock 2023-12-15 M A 31,750 $0.00 56,992 D — — (F1) On December 5, 2022, the Reporting Person was granted 127,000 time-based restricted stock units ("RSUs"), subject to a 4-year vesting schedule, with 25% of the total number of RSUs to vest on December 15, 2023 (the "Annual Vesting Date") and 25% of the total number of RSUs to vest in annual installments on each anniversary of the Annual Vesting Date thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). On December 15, 2023, 31,750 RSUs vested, with 10,980 shares being withheld for taxes, resulting in a net issuance of 20,770 shares. (F2) Each RSU represents a contingent right to receive one share of SPRB common stock.
3 Derivative Restricted Stock Units 2023-12-14 A A 212,800 $0.00 212,800 D $0.00 · — to — 212,800 Common Stock (F2) Each RSU represents a contingent right to receive one share of SPRB common stock. (F4) 106,400 of the RSUs shall vest upon the achievement of specified performance goals, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). (F3) 106,400 of the RSUs shall vest as to 25% on December 15, 2024, and in equal annual installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan).
4 Derivative Restricted Stock Units 2023-12-15 M D 31,750 $0.00 95,250 D $0.00 · — to — 31,750 Common Stock (F5) Represents the aggregate balance of 95,250 time-based RSUs. (F2) Each RSU represents a contingent right to receive one share of SPRB common stock. (F1) On December 5, 2022, the Reporting Person was granted 127,000 time-based restricted stock units ("RSUs"), subject to a 4-year vesting schedule, with 25% of the total number of RSUs to vest on December 15, 2023 (the "Annual Vesting Date") and 25% of the total number of RSUs to vest in annual installments on each anniversary of the Annual Vesting Date thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). On December 15, 2023, 31,750 RSUs vested, with 10,980 shares being withheld for taxes, resulting in a net issuance of 20,770 shares.